Here are four takeaways:
1. Asia is expected to see high market growth because of research and development activities, more government funding and improved healthcare infrastructure.
2. China, India and Japan will experience the most growth in Asia due to growing economies.
3. Costly neurosurgery equipment, strict regulations and unfavorable reimbursements will prove detrimental to the market’s growth.
4. Some key market players include Doman & Shurtleff, Medtronic, B. Braun Melsungen, Stryker, BrainLab, Integra LifeSciences, NeuroVista and Scopis GmbH.
More articles on devices:
How will Stryker’s acquisitions impact the company? 5 key notes
Stryker buys Physio-Control for $1.28B in 3rd February 2016 acquisition: 6 key notes
Medtech sells ROSA system in France: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
